User profiles for Arezou Khosroshahi

Arezou Khosroshahi

Emory
Verified email at emory.edu
Cited by 13387

[HTML][HTML] Consensus statement on the pathology of IgG4-related disease

…, G Klöppel, JG Heathcote, A Khosroshahi… - Modern …, 2012 - nature.com
IgG4-related disease is a newly recognized fibro-inflammatory condition characterized by
several features: a tendency to form tumefactive lesions in multiple sites; a characteristic …

The 2019 American College of Rheumatology/European league against rheumatism classification criteria for IgG4‐related disease

…, D Inoue, M Kawano, A Khosroshahi… - Arthritis & …, 2020 - Wiley Online Library
Objective IgG4‐related disease (IgG4‐ RD ) can cause fibroinflammatory lesions in nearly
any organ. Correlation among clinical, serologic, radiologic, and pathologic data is required …

International consensus guidance statement on the management and treatment of IgG4‐related disease

A Khosroshahi, ZS Wallace, JL Crowe… - Arthritis & …, 2015 - Wiley Online Library
IgG4-related disease (IgG4-RD) is an immunemediated fibroinflammatory condition that can
affect multiple organs and lead to tumefactive, tissuedestructive lesions and organ failure (1)…

[HTML][HTML] IgG4-related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations

JH Stone, A Khosroshahi, V Deshpande… - Arthritis and …, 2012 - ncbi.nlm.nih.gov
During the first decade of this century, recognition of a multi-organ system disease known
as IgG4-related disease (IgG4-RD) has grown. Serum IgG4 elevation (in some patients) and …

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease

A Khosroshahi, DB Bloch, V Deshpande… - Arthritis & …, 2010 - Wiley Online Library
Objective Patients with IgG4‐related systemic disease (IgG4‐RSD) frequently show an
incomplete response to treatment with glucocorticoids and traditional disease‐modifying …

Rituximab for IgG4-related disease: a prospective, open-label trial

MN Carruthers, MD Topazian, A Khosroshahi… - Annals of the …, 2015 - ard.bmj.com
Objectives To evaluate the efficacy of rituximab (RTX) in IgG4-related disease (IgG4-RD) in
an open-label pilot trial. Methods We treated 30 IgG4-RD patients with two doses of RTX (…

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients

A Khosroshahi, MN Carruthers, V Deshpande… - Medicine, 2012 - journals.lww.com
Patients with IgG4-related disease (IgG4-RD) typically have elevated serum concentrations
of IgG4 and share histopathologic features that are similar across affected organ (s). IgG4-…

The diagnostic utility of serum IgG4 concentrations in IgG4-related disease

MN Carruthers, A Khosroshahi, T Augustin… - Annals of the …, 2015 - ard.bmj.com
Objectives We evaluated the sensitivity, specificity and positive and negative predictive values
of elevated serum IgG4 concentrations for the diagnosis of IgG4-RD. Methods Between …

A critical role for the programmed death ligand 1 in fetomaternal tolerance

I Guleria, A Khosroshahi, MJ Ansari, A Habicht… - The Journal of …, 2005 - rupress.org
Fetal survival during gestation implies that tolerance mechanisms suppress the maternal
immune response to paternally inherited alloantigens. Here we show that the inhibitory T cell …

A clinical overview of IgG4-related systemic disease

A Khosroshahi, JH Stone - Current opinion in rheumatology, 2011 - journals.lww.com
IgG4-RSD is an underrecognized condition about which knowledge is now growing rapidly.
Yet there remain many unknowns with regard to its cause, pathogenesis, various clinical …